Sino Biopharmaceutical
Beijing, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A leading Chinese pharmaceutical conglomerate with a diversified portfolio in oncology and other major therapeutic areas.
OncologyHepatologyRespiratory
Technology Platform
Integrated R&D platform covering small molecules, biologics, and biosimilars, supported by large-scale manufacturing.
Opportunities
Leveraging its commercial scale to launch innovative drugs in China's rapidly growing healthcare market.
Risk Factors
Exposure to Chinese drug pricing reforms and pressure to deliver successful late-stage innovative clinical trials.
Competitive Landscape
A top-tier player in China competing with both domestic giants and multinational corporations, especially in oncology.